NDC 50564-555

Orphenadrine Citrate Aspirin Caffeine

Orphenadrine Citrate, Aspirin, Caffeine

Orphenadrine Citrate Aspirin Caffeine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Jerome Stevens Pharmaceuticals, Inc.. The primary component is Orphenadrine Citrate; Aspirin; Caffeine.

Product ID50564-555_71f2aff4-c5dd-4a71-b740-30a94acc9e10
NDC50564-555
Product TypeHuman Prescription Drug
Proprietary NameOrphenadrine Citrate Aspirin Caffeine
Generic NameOrphenadrine Citrate, Aspirin, Caffeine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1999-04-30
Marketing CategoryANDA /
Application NumberANDA074988
Labeler NameJerome Stevens Pharmaceuticals, Inc.
Substance NameORPHENADRINE CITRATE; ASPIRIN; CAFFEINE
Active Ingredient Strength50 mg/1; mg/1; mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50564-555-01

100 TABLET in 1 BOTTLE (50564-555-01)
Marketing Start Date1999-04-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Orphenadrine Citrate Aspirin Caffeine" or generic name "Orphenadrine Citrate, Aspirin, Caffeine"

NDCBrand NameGeneric Name
50564-554Orphenadrine Citrate Aspirin CaffeineOrphenadrine Citrate, Aspirin, Caffeine
50564-555Orphenadrine Citrate Aspirin CaffeineOrphenadrine Citrate, Aspirin, Caffeine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.